Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D, EINSTEIN-Jr Phase 2 Investigators.

Open source

DOI: 10.1016/s2352-3026(19)30161-9
Published: 2019-08-13
Container: Lancet Haematol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-19-30161-9,
  title = {Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.},
  author = {Monagle P and  Lensing AWA and  Thelen K and  Martinelli I and  Male C and  Santamaría A and  Samochatova E and  Kumar R and  Holzhauer S and  Saracco P and  Simioni P and  Robertson J and  Grangl G and  Halton J and  Connor P and  Young G and  Molinari AC and  Nowak-Göttl U and  Kenet G and  Kapsa S and  Willmann S and  Pap AF and  Becka M and  Twomey T and  Beyer-Westendorf J and  Prins MH and  Kubitza D and  EINSTEIN-Jr Phase 2 Investigators.},
  year = {2019},
  journal = {Lancet Haematol},
  doi = {10.1016/s2352-3026(19)30161-9},
  url = {https://doi.org/10.1016/s2352-3026(19)30161-9}
}

RIS

TY  - JOUR
TI  - Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.
AU  - Monagle P
AU  -  Lensing AWA
AU  -  Thelen K
AU  -  Martinelli I
AU  -  Male C
AU  -  Santamaría A
AU  -  Samochatova E
AU  -  Kumar R
AU  -  Holzhauer S
AU  -  Saracco P
AU  -  Simioni P
AU  -  Robertson J
AU  -  Grangl G
AU  -  Halton J
AU  -  Connor P
AU  -  Young G
AU  -  Molinari AC
AU  -  Nowak-Göttl U
AU  -  Kenet G
AU  -  Kapsa S
AU  -  Willmann S
AU  -  Pap AF
AU  -  Becka M
AU  -  Twomey T
AU  -  Beyer-Westendorf J
AU  -  Prins MH
AU  -  Kubitza D
AU  -  EINSTEIN-Jr Phase 2 Investigators.
PY  - 2019
JO  - Lancet Haematol
DO  - 10.1016/s2352-3026(19)30161-9
UR  - https://doi.org/10.1016/s2352-3026(19)30161-9
ER  -

APA

P, M., AWA, L., K, T., I, M., C, M., A, S., E, S., R, K., S, H., P, S., P, S., J, R., G, G., J, H., P, C., G, Y., AC, M., U, N., G, K., S, K., S, W., AF, P., M, B., T, T., J, B., MH, P., D, K., & Investigators., E. P. 2. (2019). Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.. Lancet Haematol. https://doi.org/10.1016/s2352-3026(19)30161-9

Source records

europe-pmc · retrieved 2026-09-26T15:43:57.473Z